Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the east Midlands UK - a retrospective observational study.
CONCLUSIONS: Results in this predominately anti-TNF experienced population mirror other published real-world data, demonstrating good clinical effectiveness and a comparable safety profile.
PMID: 32657179 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Bleeding | Clinical Trials | Corticosteroid Therapy | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | PET Scan | Study | Ulcerative Colitis